They include LE and rheumatoid arthritis (RA), where LL-37 is present in affected organs, such as the skin and kidneys, or in synovial fluids and circulation, respectively [47,48,49] (Table 1). This evidence concerns the gene CAMP and rheumatoid arthritis.